The Pennant Group Inc. Common Stock (PNTG)
PNTG trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1766400/000176640026000014/0001766400-26-000014-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | PNTG on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001766400 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $947.7M |
| Net income | $29.6M |
| Operating income | $51.9M |
| Net margin | 3.1% |
| Operating margin | 5.5% |
| Revenue growth | +36.3% |
| Cash | $17.0M |
| Total assets | $968.2M |
| P/E (computed) | 44.0× |
| P/S (computed) | 1.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-04 |
| Cash and burn | $18.4M cash; operating cash flow $16.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 35,132,364 (2026-11-02); 34,593,720 a year earlier; 29,926,501 three years earlier. | Cover page 2026-11-02 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, Boise, Idaho, United States | PCAOB Form AP 2026-03-08 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $690K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $302.3M | $9.6M | $25.1M | $18.4M | $193.3M | $1.2B | 10-Q 2026-11-04 |
| Q2 2026 2026-06-30 | $298.0M | $9.1M | $21.8M | $15.3M | $192.5M | $1.1B | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $285.4M | $8.5M | -$3.4M | $4.9M | $164.7M | $1.0B | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $289.3M | $8.6M | $21.0M | $17.0M | $168.8M | $947.7M | 10-K 2026-02-26 |
| Q3 2025 2025-09-30 | $229.0M | $6.1M | $13.9M | $2.3M | $26.0M | $847.3M | 10-Q 2026-11-04 |
| Q2 2025 2025-06-30 | $219.5M | $7.1M | $34.6M | $14.4M | $37.0M | $798.9M | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $209.8M | $7.8M | -$21.2M | $5.2M | $52.5M | $748.2M | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $188.9M | $5.8M | $20.6M | $24.2M | $0 | $695.2M | 10-K 2026-02-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-10-03 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-11-04 |
| Latest current report | 8-K | 2026-11-04 |
| Latest proxy | DEF 14A | 2026-03-31 |
Source: SEC EDGAR submissions feed, 536 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.8% |
| 1 month | -10.2% |
| 3 months | -6.7% |
| Year to date | +28.1% |
| 1 year | +44.9% |
| From 52-week high | -18.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier